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Summary.-During the terminal stages of tumour growth (6-8 weeks) in Wistar
rats bearing a syngeneic squamous cell carcinoma (Spl), their sera can block in
vitro anti-tumour cytotoxicity by immune splenic T lymphocytes. At an earlier
stage of tumour growth (4-6 weeks) the sera do not block this cytotoxicity, but can
induce anti-tumour cytotoxicity by non-immune spleen cells in the absence of
complement. Sera taken at these 2 stages of tumour growth have been fractiona-
ted by ion-exchange chromatography, using DEAE-cellulose. The fractions have
been examined by immunoelectrophoresis and tested for anti-tumour reactivity.
Blocking activity was found in the Week-8 serum fraction eluted with 0005M
phosphate buffer, pH 7-4, whilst the " cytotoxic " activity of Week-4 serum was
eluted with 0-02M phosphate buffer, pH 6-2. It is suggested that different IgG
sub-classes are responsible for the 2 activities.
IN RATS bearing a syngeneic squamous
cell carcinoma (Spl), in vitro anti-tumour
cytotoxicity by splenic T lymphocytes
can be detected 4 weeks after tumour
induction, and persists until death of the
host after 8 weeks (Flannery et al., 1973a;
Matthews et al., 1976). After 6 weeks
of tumour growth, factors appear in the
serum, capable of blocking this cyto-
toxicity. The serum effect is expressed
at the tumour-cell and not at the lympho-
cyte level, suggesting a role for anti-
tumour antibodies, or perhaps complexes
of these antibodies and tumour-derived
antigen in antibody excess.
At an earlier stage of tumour growth
(4-6 weeks), at the height of the comple-
ment-dependent antibody response to the
tumour, sera at high dilutions can induce
in vitro anti-tumour cytotoxicity by
non-immune spleen cells in the absence of
complement (Flannery et al., 1973b;
Matthews et al., 1976).
Thus, at different stages of tumour
growth, 2 functionally distinct types of
antibody response to the Spl tumour can
be detected: one type of response
apparently favouring tumour growth, the
other helping to prevent it.
MATERIALS AND METHODS
Cytotoxicity tests.-Inbred Wistar rats
were inoculated s.c. in the thigh with 104 cells
of the syngeneic squamous cell carcinoma
Spl, which originated spontaneously and was
obtained by courtesy of Professor R. W.
Baldwin, Nottingham. Other tumours, used
for specificity testing, were the Sp24 and Mc7
fibrosarcomas, also obtained from Professor
Baldwin, and syngeneic with the WTistar
rats, and a spontaneous mammary tumour
(MRMC2) of inbred DA rats provided by
Dr M. N. Cauchi of this department. Cyto-
toxic spleen cells were obtained from Wistar
rats after 4-8 weeks of Spl tumour growth,
and serum blocking was determined as
described previously (Flannery et al., 1973b).
Briefly, 10 ,ul of heat-inactivated serum or
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serum fractions was incubated for 1 h at
37°C with 50-100 plated Spl tumour cells
in Falcon microtest plates (3034). The
plates were washed once, and cytotoxic
spleen cells were added in a volume of 10 ,ul
to give an effector:target cell ratio of 100:1.
After a 4-h incubation at 37°C, plates were
washed gently to remove spleen cells non-
adherent to Spl cells, and then the incubation
w,as continued for a further 2 days. The
plates were washed and fixed, and the
remaining tumour cells in each well were
counted by phase-contrast microscopy. Per-
cent blocking was calculated as 100 (Cn-Ct)/
Cn where Cn and Ct are respectively the
cytotoxicities of the spleen cells in the
presence of normal and test sera. For
specificity tests of serum blockade, spleen
cells from a DA rat that had borne the
MRMC2 tumour for 10 days were used as
cytotoxic cells, and normal DA spleen cells
were used as controls.
Antibody-induced lymphoid cell cyto-
toxicity was determined as described
previously (Matthews et al., 1976) using
normal spleen cells, and serum or serum
fractions at a dilution of 1/5. Percent
cytotoxicity was calculated from the formula
100 (Nn-Nt)/Nn where Nn and Nt are
respeetively the mean number of surviving
Spl cells in wells with spleen cells plus
normal or test serum.
Ion-exchange chromatography.-Sera were
pooled from 4 animals after 4 or 8 weeks of
tumour growNth. One ml of heat-inactivated
serum was exhaustively dialysed against
O-O1M phosphate buffer, pH 7*4, and applied
to a 5-ml bed volume column of DEAE-
cellulose (Whatman 52) equilibrated with
the same buffer. Stepwise elution at room
temperature was performed with the follow-
ing buffers: 0-O1M, pH 7-4 (Fraction I);
0-02M, pH 6-2 (Fraction II); 0(05M, pH 4*5
(Fraction III) and 0-2M, pH 4-5 (Fraction
IV). In one experiment, the serum and
column were equilibrated with 0-005M phos-
phate buffer, pH 7 4, and elution was
performed initially with the same buffer
(Fraction I') and then with the following
phosphate buffers: 0O01M, pH 7-4 (Fraction
II'); 0-02M, pH 6-2 (Fraction III') and 0-2M,
pH 4-5 (Fraction IV'). Fractions eluted
with each buffer were dialysed against
isotonic saline and concentrated to 1 ml by
negative pressure dialysis and then niem-
brane-sterilized.
Immunoelectrophoresis.-The method of
Scheidegger (1955) was employed, using
1-3%o Oxoid Jonagar No. 2 in a veronal
buffer of ionic strength 0f025M and pH 8 2.
The antiserum was raised in a rabbit against
a y-globulin fraction precipitated from rat
serum with 330/,, saturated ammonium sul-
phate solution.
Absorption uithanti-IgG.-Tumour-bearer
sera and their fractions were tested for
activity after absorption with a rabbit
anti-rat IgG serum that had been poly-
merized with glutaraldehyde. The rabbit
anti-rat IgG was prepared by immunization
with DEAE-cellulose-purified rat IgG and on
immunoelectrophoresis gave a single
precipitin line against whole rat serum.
The anti-IgG serum was rendered insoluble
by the method of Avrameus and Ternynck
(1969). Briefly, 1 ml of IM phosphate buffer,
pH 7 0, was added to 10 ml of serum, and
3 ml of 2.5% glutaraldehyde was added
slowly, witl-h stirring at room temperature.
After 3 h, the gel that formed was
homogenized in 0-2M phosphate buffer,
pH 7 0, and centrifuged at 3000g for 15 min.
The gel was washed a further 4 times, the
final time in phosphate-buffered saline. For
absorption, 0 3 ml of packed gel was in-
cubated with 0-2 ml of whole serum or
fractions, diluted 1 in 5, for 1 h at room
temperature.
RESULTS
Week-4 and Week-8 sera gave very
similar elution profiles when fractionated
by ion-exchange chromatography under
identical conditions (Fig. 1, top and
centre). The eluates were pooled into
4 fractions, I-IV, and tested for ability
to block cytotoxicity by immune spleen
cells from tumour-bearing rats. Table I
shows that most of the blocking activity
of Week-8 serum is contained in Fraction
I; there was no such activity in Week-4
serum or any of its fractions. Using
different elution conditions (Fig. 1,
bottom), the blocking activity of Week-8
serum was again found in the first fraction
eluted (Fraction I'); in this case with
0-005M phosphate buffer, pH 7*4. Frac-
tion I' reacted with anti-immunoglobulin
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FIG. 1. Fractionation of Week-4 (top) and
Week-8 (centre and bottom) sera by step-
wvise ion-exchange chromatography using
DEAE-cellulose and phosphate buffers.
Buffers used were: (a) O-OlM, pH 7-4; (b)
0-02M, pH 6-2; (C) 0-05M, pH 4-5; (d) 0-2mu,
pH 4-5; (e) 0-005M, pH7-4.
serum on electrophoresis and had a
marked cathodal distribution (Fig. 2k).
Week-4 serum does not block anti-
tumour cytotoxicity by immune spleen
cells, but can induce anti-tumour cyto-
44
FiG. 2.-Immunoelectrophoretic analysis of
tumour-bearer sera and their DEAE-cellu-
lose-separated fractions against rabbit anti-
rat y globulin. (a) Whole Week-8 serum;
(b) whole Week-4 serum; (c)-(f) fractions
1-IVofWeek-4 serum; (g)-(j)fractionsT-IV
of Week-8 serum; (k)-(n) fractions I'-IV'
of Week-8 serum. Anode on left.
toxicity by non-immune spleen cells.
Table II shows that this activity resides
primarily in Fraction II, eluted with
0-02M phosphate buffer, pH 6-2. No
such activity was found in Week-8 serum
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TABLE I.-Blocking Activity ofDEAE-Cellulose Fractions of Tumour-bearer Serum
Before and After Absorption with Anti-rat IgG
Before absorption After absorption
Serum fraction
Normal
Whole Week-4
I (a)
II (b)
III (c)
IV (d)
Normal
Whole Week-8
I (a)
II (b)
III (c)
IV (d)
Normal
WVhole Week-8
I' (e)
II' (a)
III' (b)
IV' (d)
% Cytotoxicity
19.0**
18 - 3**
17.2*
19*8**
19-7*
17-2*
24- 3**
-0.5
4-0
13-0*
25 -6***
20-6*
30-6**
8-2
7-5
34.0***
34 0***
33 -6***
% Blocking % Cytotoxicity
3-7
9.5
--4-2
-3 -7
9.5
102 -6*
83 -5**
46-5
-5 -3
15 -3
73-2*
75 -5***
-11*1
-11-1
-9-8
25. *5**
33-1**
23 - 7**
33 -5**
33 -8***
32 -4***
* Significant P < 0-05; ** Significant P < 0-01; *** Significant P < 0-001; Not done. Eluting
buffers in brackets. See legend to Fig. 1.
or any of its fractions (Table II). The
immunoelectrophoretic distribution of
Fractions I-IV of Week-4 serum is shown
in Fig. 2c-f; of Fractions I-IV and
Fractions I'-IV' of Week-8 serum in
Fig. 2g-j and k-n respectively.
Both the serum-blocking activity in
Week-8 serum and Fraction I' of it
TABLE II.-Antibody-dependent Cytotoxi-
city Induced by Fractions of Tumour-
bearer Serum Before and After Absorp-
tion with Anti-rat IgG
(Table I), and the ability to induce
cytotoxicity by normal spleen cells found
in Week-4 serum and Fraction II of it
(Table II) were abolished by absorption
with insoluble anti-IgG.
Neither Week-4 serum nor any of its
fractions could evoke cytot6xicity media-
ted by normal spleen cells against the
tumours Sp24, Mc7 or MRMC2 (Table
III). Similarly, neither Week-8 serum
nor any of its fractions could block
cytotoxicity against MRMC2 cells effected
by DA spleen cells immune to MRMC2.
Serum fraction
Whole Week-4
I (a)
II (b)
III (c)
IV (d)
Whole Week-8
I (a)
II (b)
III (c)
IV (d)
Whole Week-8
I' (e)
II' (a)
III' (b)
IV' (d)
% Cytotoxicity
18-4*
-7- 0
21-7*
-5-2
-7 9
-2-5
6-3
-0-6
9-2
-6-9
-1-5
8-3
4-3
6114
11
-
% Cytotoxicity
after absorption
-1-1
-5- 9
-21-2
-3-5
1-5
* Significant P < 0- 05; Not done. Eluting
buffers in brackets. See legend to Fig. 1.
DISCUSSION
The immunological blocking activity
of Week-8 serum was almost entirely
confined to Fractions I and I' eluted
from DEAE-cellulose with dilute phos-
phate buffers (i.e. O-O1M and 0-005M
respectively, pH 7-4). In contrast, the
capacity of Week-4 serum to induce
lymphoid cell cytotoxicity was found in
Fraction II, eluted with 0-02M buffer,
pH 6-2. The loss of activity by sera
absorbed with insoluble anti-IgG is strong
evidence that the activities are associated
with serum IgG. The tumour-specificity
% Blocking
-29 -8
7-1
-31 -4
-32-6
-27-1
S~~~~~~~~~~~~~~~~~
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TABLE III.-Speciftcity ofSerum Blocking Activity and Antibody-dependent
Cytotoxicity
Target cells Spl MRMC2 Mc7 Sp24
Serum fractions % Blocking
Whole Week-8 73.2* 4.3 3
I' (e) 75 5*** 26 -
II' (a) -11*1 14 8
Ill' (b) -11-1 21-4-
IV' (d) -9-8 13 -
% Cytotoxicity
Whole Week-4 27 5*** 5 7 -0o8 -11*6
I (a) 1-3 0 8 2 1 -5 6
II (b) 24 2** 2-0 5 8 -4*6
III (C) 4.3 3 1 -2-1 12-9
IV (d) 1.5 4 6 -1 3 -6 3
* Significant P < 0 05; ** Significant P < 0-01; * Significant P < 0-001; Not done. Eluting
buffers in brackets. See legend to Fig. 1.
of both the blockade and the antibody-
dependent cytotoxicity, established by
the negative results with the control
tumours (Table III), is further evidence
of the antibody nature of the active
serum components.
The elution buffers to obtain the
serum fractions were similar to those
used by others (Bloch, Morse and Austen,
1968; Jones, Edwards and Ogilvie, 1970)
who found that these buffers separated
rat IgG sub-classes. Although specific
anti-sub-class sera were not available
to identify our serum fractions, the
immunoelectrophoretic analysis of the
fractions shows that they differ in charge
as well as function, and the assumption
that they contain different IgG sub-
classes seems justified.
The factors that block lymphocyte
cytotoxicity in Week-8 sera do not behave
as anything other than free antibody
molecules. There is no evidence that they
are complexes, as have been demonstrated
for other systems (Sjogren et al., 1971;
Baldwin, Price and Robins, 1972), al-
though they have not been subjected to
rigorous dissociating conditions.
The antibody which induces cyto-
toxicity by non-immune spleen cells (i.e.
K cells and macrophages) does not block
cytotoxicity by immune splenic T lympho-
cytes, and thus may bind to different Spl
antigens from those recognized by the
T cells. However, blocking antibody and
cytotoxic T cells must compete for the
same, or adjacent, antigenic determinants.
These determinants may be so distributed
on the tumour cell surface, that the Fc
region of the blocking antibody is not
sufficiently altered to bind to, and hence
activate, K lymphocytes or macrophages.
Alternatively, pos4ible differences in
antibody sub-class suggest that blocking
antibodies bound to tumour cells do not
have the appropriate configuration in
their Fc regions to activate antibody-
dependent cytotoxic cells.
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